Pam Fredman
#21,378
Most Influential Person Now
President of the International Association of Universities, Professor of Neurochemistry
Why Is Pam Fredman Influential?
(Suggest an Edit or Addition)According to Wikipedia, Pam Fredman is a Swedish professor of neuroscience and former rector of the University of Gothenburg. From 2016, Fredman is the President of the International Association of Universities Biography Fredman graduated with a Master of Science in Chemical Engineering at Chalmers University of Technology in 1973 and a Doctor of Philosophy in Neurochemistry in 1979. Her thesis is titled ”Structure and Function of Gangliosides”.
Pam Fredman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. (1994) (682)
- A procedure for the quantitative isolation of brain gangliosides. (1980) (680)
- CD62/P-selectin recognition of myeloid and tumor cell sulfatides (1991) (281)
- Human brain gangliosides: developmental changes from early fetal stage to advanced age. (1989) (270)
- A population study on blood-brain barrier function in 85-year-olds (1998) (238)
- Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent‐resistant membrane domains (2005) (208)
- Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides. (1983) (188)
- Blood‐brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors (1990) (180)
- Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord. (1994) (179)
- Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. (1993) (169)
- Dynamic association of human insulin receptor with lipid rafts in cells lacking caveolae (2002) (168)
- A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality (1998) (163)
- Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin (1982) (144)
- Lipids and glycosphingolipids in caveolae and surrounding plasma membrane of primary rat adipocytes. (2004) (142)
- White matter changes in normal pressure hydrocephalus and Binswanger disease: specificity, predictive value and correlations to axonal degeneration and demyelination (2002) (136)
- Monoclonal antibody A2B5 reacts with many gangliosides in neuronal tissue. (1984) (125)
- Separation of gangliosides on a new type of anion-exchange resin. (1980) (123)
- Characterization of the binding epitope of a monoclonal antibody to sulphatide. (1988) (114)
- Polystyrene-adsorbed gangliosides for investigation of the structure of the tetanus-toxin receptor. (1980) (114)
- Comparison of receptors for cholera and Escherichia coli enterotoxins in human intestine. (1985) (109)
- Chemical structure of carcinoma ganglioside antigens defined by monoclonal antibody C-50 and some allied gangliosides of human pancreatic adenocarcinoma. (1985) (106)
- Sendai virus receptor: proposed recognition structure based on binding to plastic-adsorbed gangliosides. (1980) (106)
- Activation of the complement cascade and increase of clusterin in the brain following a cortical contusion in the adult rat. (1996) (104)
- Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease. (1994) (100)
- Blood brain barrier function in vascular dementia (1990) (96)
- Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. (1994) (94)
- Clusterin in cerebrospinal fluid: Analysis of carbohydrates and quantification of native and glycosylated forms (2006) (94)
- Measurement of Apolipoprotein E (apoE) in Cerebrospinal Fluid (2000) (93)
- Antibody detection in Guillain‐Brré syndrome (1990) (88)
- CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy (2000) (83)
- Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio. (1993) (82)
- Protein Analysis in Cerebrospinal Fluid (1993) (80)
- Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'. (1991) (76)
- Membrane lipids of human peripheral nerve and spinal cord. (1992) (74)
- Gangliosides as receptors for bacterial toxins and Sendai virus. (1980) (73)
- A monoclonal antibody that precipitates the glycoprotein receptor for epidermal growth factor is directed against the human blood group H type 1 antigen. (1983) (71)
- Quality Assurance for Cerebrospinal Fluid Protein Analysis: International Consensus by an Internet-Based Group Discussion (2003) (71)
- Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations (2002) (69)
- Characterization of new gangliosides of the lactotetraose series in murine xenografts of a human glioma cell line (1986) (69)
- Sulphatide and sulphatide antibodies in insulin-dependent diabetes mellitus (1993) (68)
- Increased levels of cholesterol esters in glioma tissue and surrounding areas of human brain. (1997) (67)
- Determination of gangliosides and sulfatide in human cerebrospinal fluid with a microimmunoaffinity technique. (1991) (67)
- S100 in mild traumatic brain injury (2004) (65)
- Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform. (1996) (62)
- A sulfated glucosylceramide from rat kidney. (1989) (62)
- Gangliosides in Human Fetal Brain (1991) (62)
- The glycosphingolipid sulfatide in the islets of Langerhans in rat pancreas is processed through recycling: possible involvement in insulin trafficking. (2000) (60)
- Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia (1992) (58)
- Sialyllactotetraosylceramide, a Ganglioside Marker for Human Malignant Gliomas (1988) (58)
- Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus (2007) (58)
- Large Alterations in Ganglioside and Neutral Glycosphingolipid Patterns in Brains from Cases with Infantile Neuronal Ceroid Lipofuscinosis/Polyunsaturated Fatty Acid Lipidosis (1987) (57)
- Accumulation of sulfatide in neuronal and glial cells of arylsulfatase A deficient mice (2004) (56)
- Structural characterization of the GM1 ganglioside by infrared multiphoton dissociation, electron capture dissociation, and electron detachment dissociation electrospray ionization FT-ICR MS/MS (2005) (56)
- Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin (1991) (55)
- Expression of the myelin and oligodendrocyte progenitor marker sulfatide in neurons and astrocytes of adult rat brain (2002) (54)
- Sulfatide promotes the folding of proinsulin, preserves insulin crystals, and mediates its monomerization. (2001) (53)
- Lysosulfatide (Galactosylsphingosine‐3‐O‐Sulfate) from Metachromatic Leukodystrophy and Normal Human Brain (1989) (52)
- Normal pressure hydrocephalus triggers intrathecal production of TNF-α (2003) (52)
- Sulfatide controls insulin secretion by modulation of ATP-sensitive K(+)-channel activity and Ca(2+)-dependent exocytosis in rat pancreatic beta-cells. (2002) (50)
- Potential ganglioside antigens associated with human gliomas. (1986) (50)
- Binding specificities of the lectins PNA, WGA and UEA I to polyvinylchloride‐adsorbed glycosphingolipids (1986) (49)
- Intracerebroventricular administration of GM1 ganglioside to presenile Alzheimer patients. (1997) (49)
- Gangliosides as Therapeutic Targets for Cancer (2012) (49)
- Expression of Gangliosides GD3 and 3′‐isoLM1 in Autopsy Brains from Patients with Malignant Tumors (1993) (45)
- Ganglioside Composition in Human Meningiomas (1989) (44)
- Receptor ganglioside content of three hosts for Sendai virus. MDBK, HeLa, and MDCK cells. (1984) (44)
- Monoclonal antibody 18B8 detects gangliosides associated with neuronal differentiation and synapse formation. (1985) (42)
- Increased cerebrospinal fluid ganglioside GD3 concentrations as a marker of microglial activation in HIV type 1 infection. (1998) (42)
- Involvement of sulfatide in beta cells and type 1 and type 2 diabetes (2005) (42)
- Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus (2008) (41)
- Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues. (2000) (40)
- Normal pressure hydrocephalus triggers intrathecal production of TNF-alpha. (2003) (40)
- Sulphatide antigen in islets of Langerhans and in diabetic glomeruli, and anti‐sulphatide antibodies in Type 1 diabetes mellitus (1993) (39)
- Occurrence of Lacto Series Gangliosides 3'-isoLM1 and 3',6'-isoLD1 in Human Gliomas in vitro and in vivo (1991) (39)
- Monoclonal antibody 101 that precipitates the glycoprotein receptor for epidermal growth factor is directed against the Y antigen, not the H type 1 antigen. (1985) (39)
- Parenteral administration of GM1 ganglioside to presenile Alzheimer patients (1990) (39)
- Beta-galactosylceramide increases and sulfatide decreases cytokine and chemokine production in whole blood cells. (2004) (39)
- Chloroquine Intoxication Induces Ganglioside Storage in Nervous Tissue: A Chemical and Histopathological Study of Brain, Spinal Cord, Dorsal Root Ganglia, and Retina in the Miniature Pig (1981) (39)
- Gangliosides in the human glioma cell line U-118 MG grown in culture or as xenografts in nude rats. (1990) (38)
- Binding specificity of monoclonal antibodies to ganglioside, Fuc-GM1. (1986) (38)
- Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions. (1997) (37)
- Chapter 16 Detection of glioma-associated gangliosides GM2, GD2, GD3, 3′-isoLM1 and 3′,6′-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodies (1994) (37)
- Treatment with Sulfatide or its Precursor, Galactosylceramide, Prevents Diabetes in NOD Mice (2001) (37)
- Normal levels of clusterin in cerebrospinal fluid in Alzheimer's disease, and no change after acute ischemic stroke. (2001) (36)
- Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas (1991) (36)
- Immunoglobulin M in cerebrospinal fluid: reference values derived from 111 healthy individuals 18-88 years of age. (1996) (34)
- Formulas for the quantitation of intrathecal IgG production Their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis (1994) (34)
- BINDING OF INTRALUMINAL TOXIN IN CHOLERA: TRIAL OF GM1 GANGLIOSIDE CHARCOAL (1980) (33)
- Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines. (1989) (32)
- Differences in cerebrospinal fluid dynamics do not affect the levels of biochemical markers in ventricular CSF from patients with aqueductal stenosis and idiopathic normal pressure hydrocephalus (2004) (32)
- Monosialoganglioside (GM1) immunofluorescence in rat spinal roots studied with a monoclonal antibody (1997) (31)
- C16:0 Sulfatide Inhibits Insulin Secretion in Rat β-Cells by Reducing the Sensitivity of KATP Channels to ATP Inhibition (2006) (31)
- Gangliosides associated with primary brain tumors and their expression in cell lines established from these tumors. (1994) (30)
- Sulphatide in islets of Langerhans and in organs affected in diabetic late complications: a study in human and animal tissue (1994) (29)
- Low serum concentration of sulfatide and presence of sulfated lactosylceramid are associated with Type 2 diabetes. The Skaraborg Project (2005) (29)
- Immunostaining of ganglioside GD1b, GD3 and GM1 in rat cerebellum: Cellular layer and cell type specific associations (2000) (28)
- IL-10 and IFN-γ in Guillain–Barré syndrome (2001) (28)
- Glycosphingolipid Antibodies in Serum in Patients With Sciatica (2002) (28)
- Identification of defensins in human lymphocyte nuclei. (1999) (28)
- Chemical structures of three fucogangliosides isolated from nervous tissue of mini-pig. (1981) (28)
- Sulfatide is expressed in both erythrocytes and platelets of bovine origin. (1996) (27)
- Correlation between Intrathecal Sulfatide and TNF-α Levels in Patients with Vascular Dementia (2003) (27)
- Haptoglobins as markers of blood–CSF barrier dysfunction: the findings in normal CSF (2001) (27)
- Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro (2000) (27)
- In vivo administration of the C16:0 fatty acid isoform of sulfatide increases pancreatic sulfatide and enhances glucose‐stimulated insulin secretion in Zucker fatty (fa/fa) rats (2005) (27)
- Determination of Gangliosides in Six Human Primary Medulloblastomas (1990) (26)
- Production and characterization of two human glioma xenograft-localizing monoclonal antibodies. (1986) (26)
- Inhibition of insulin-specific autoreactive T-cells by sulphatide which is variably expressed in beta cells (1999) (26)
- Patients with Insulin-dependent Diabetes but not those with Non-insulin-dependent Diabetes have Anti-sulfatide Antibodies as Determined with a New ELISA Assay (2002) (26)
- Anti-GM2 monoclonal antibodies induce necrosis in GM2-rich cultures of a human glioma cell line. (1991) (25)
- Lactotetraose series ganglioside 3',6'-isoLD1 in tumors of central nervous and other systems in vitro and in vivo. (1993) (25)
- Intracellular sulfatide expression in a subpopulation of astrocytes in primary cultures (1998) (25)
- Effect of chloroquine on the activity of some lysosomal enzymes involved in ganglioside degradation. (1987) (25)
- Selective lack of the C16:0 fatty acid isoform of sulfatide in pancreas of type II diabetic animal models (2003) (24)
- Gangliosides in serum immune complexes from tumor-bearing patients. (1985) (24)
- Gangliosides and sulphatide in human cerebrospinal fluid: quantitation with immunoaffinity techniques. (1989) (24)
- The Role of Antiglycolipid Antibodies in Neurological Disorders a (1998) (23)
- Gangliosides in cerebrospinal fluid in children with autism spectrum disorders (1998) (23)
- Multiple phenotypic changes in mice after knockout of the B3gnt5 gene, encoding Lc3 synthase--a key enzyme in lacto-neolacto ganglioside synthesis (2010) (22)
- Chloroquine-induced accumulation of gangliosides and phospholipids in skeletal muscles. Quantitative determination and characterization of stored lipids. (1981) (22)
- In vitro production of cytokines is influenced by sulfatide and its precursor galactosylceramide (1999) (22)
- A new ganglioside of the lactotetraose series, GalNAc-3'-isoLM1, detected in human meconium. (1989) (22)
- Intra‐Blood-Brain‐Barrier Synthesis of Immunoglobulins in Patients with Dementia of the Alzheimer Type (1990) (21)
- The glioma‐associated gangliosides 3′‐isoLM1, GD3 and GM2 show selective area expression in human glioblastoma xenografts in nude rat brains (2001) (21)
- Detection of glioma-associated gangliosides GM2, GD2, GD3, 3'-isoLM1 3',6'-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodies. (1994) (21)
- Expression of the Ganglioside GD3 in Human Meningiomas Is Associated with Monosomy of Chromosome 22 (1990) (21)
- Increased cerebrospinal fluid ganglioside GM1 concentrations indicating neuronal involvement in all stages of HIV-1 infection. (1997) (20)
- Sialosyllactotetraosylceramide, 3′‐isoLM1, a Ganglioside of the Lactotetraose Series Isolated from Normal Human Infant Brain (1987) (20)
- Glycosphingolipid tumor antigens. (1993) (20)
- Glycosphingolipids as Potential Diagnostic Markers and/or Antigens in Neurological Disorders (1997) (19)
- A monoclonal antibody reacting specifically with ganglioside GD1b in human brain (1985) (19)
- Sphingolipids and cell signalling (1998) (19)
- Expression of the Gm1-Species, [NeuN]-GM1, in a Case of Human Glioma (1999) (19)
- Developmental expression of the type I diabetes related antigen sulfatide and sulfated lactosylceramide in mammalian pancreas (2003) (18)
- Elevated cerebrospinal fluid sulfatide concentrations as a sign of increased metabolic turnover of myelin in HIV type I infection. (1996) (18)
- Correlation between intrathecal sulfatide and TNF-alpha levels in patients with vascular dementia. (2003) (18)
- The structure of the tetrasialoganglioside from human brain (1980) (17)
- IL-10 and IFN-gamma in Guillain-Barré syndrome. Network Members of the Swedish Epidemiological Study Group. (2001) (17)
- Concentration, composition and structure of gangliosides from the central nervous systems of dogfish, Squalus acanthia, and cod, Gadus callarias. (1982) (17)
- Sulfatide increases adiponectin and decreases TNF-α, IL-6, and IL-8 in human adipose tissue in vitro (2007) (16)
- Cancer-Associated Carbohydrate Antigens Detected by Monoclonal Antibodies (1984) (16)
- Isolation of myelinoid Marchi-positive bodies from normal rabbit spinal cord (1987) (15)
- Temporarily controlled HIV-1 replication after intravenous immunoglobulin treatment of Guillain-Barré syndrome (2005) (15)
- Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro (1994) (15)
- Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucuronyl-3-sulfate epitope (1993) (14)
- Lipid accumulation in liver, spleen, lungs and kidneys of miniature-pigs after chloroquine treatment. (1982) (14)
- Sulfatide is associated with insulin granules and located to microdomains of a cultured beta cell line (2002) (14)
- Protein analysis in cerebrospinal fluid. III. Relation to blood-cerebrospinal fluid barrier function for formulas for quantitative determination of intrathecal IgG production. (1993) (14)
- Gangliosides and sulfatide in cerebrospinal fluid in leukoaraiosis. (1997) (13)
- Colorectal carcinomas have a characteristic ganglioside pattern. (1983) (13)
- Specific Gangliosides are Receptors for Sendai Virus (1984) (13)
- Monoclonal antibodies to malignant human gliomas. (1992) (13)
- Glycolipids and glycosyltransferases in permanent cell lines established from human medulloblastomas. (1991) (12)
- A new procedure for determining ganglioside GD3 a potential glial cell activation marker in cerebrospinal fluid (1998) (12)
- Increased activity of lysosomal glycohydrolases in glioma tissue and surrounding areas from human brain (2007) (12)
- High levels in serum, but no signs of intrathecal synthesis of anti-sulfatide antibodies in HIV-1 infected individuals with or without central nervous system complications (1999) (12)
- GD3 expression by cultured human tumor cells of neuroectodermal origin (2004) (11)
- Detection of cerebrospinal fluid leakage by isoelectric focusing on polyacrylamide gels with silver staining using the PhastSystem™ (2005) (11)
- Intrathecal synthesis of immunoglobulin G in vascular dementia (1990) (10)
- GMab-1, a high-affinity anti-3'-isoLM1/3',6'-isoLD1 IgG monoclonal antibody, raised in lacto-series ganglioside-defective knockout mice. (2010) (10)
- Neonatal treatment of BB rats with sulphatide delays development of diabetes but does not change incidence (1995) (9)
- Immunoassays based on plastic-adsorbed gangliosides. (1980) (9)
- Detection of oligoclonal IgG bands in cerebrospinal fluid by immunofixation after isoelectric focusing on polyacrylamide gels with the PhastSystem (1992) (9)
- Specific gangliosides are receptors for Sendai virus. Proteins in lipid samples can mask positive biological effects. (1984) (8)
- Presence of sulphatide (3′-sulphogalactosylceramide) in pericytes in the choroid layer of the eye: sharing of this glycolipid autoantigen with islets of Langerhans (1996) (8)
- Cerebrospinal Fluid Antibodies Directed against Neuron-Associated Gangliosides in HIV-1 Infection (2000) (7)
- High‐dose intravenous immunoglobulin therapy improved muscle strength in a patient with multifocal motor neuropathy and antibodies against the glycolipid LK1 (1996) (7)
- Sulphatide as an antigen in diabetes mellitus (1996) (7)
- Gangliosides as Receptors for Cholera Toxin, Tetanus Toxin, and Sendai Virus (1980) (7)
- The presence of foetal ganglioside antigens 3′-IsoLM1 and 3′6′-IsoLD1 in both glioma tissue and surrounding areas from human brain (2007) (7)
- Uptake of the glycosphingolipid sulfatide in the gastrointestinal tract and pancreas in vivo and in isolated islets of Langerhans (2006) (7)
- Aspects of the protein and the lipid composition of myelinoid marchi-positive bodies from mammalian spinal cord (1988) (7)
- The person-centred approach to an ageing society (2013) (6)
- Circulating glycoconjugates in CSF of meningioma patients (1990) (5)
- Investigation of Intrathecal Synthesis of Immunoglobulin G in Primary Degenerative Dementia (Alzheimer's Disease) (1991) (5)
- Gangliosides of human intestinal mucosa: detection of a possible fetal antigen. (1982) (5)
- In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line (1996) (5)
- Ganglioside characterization of rat astroglial cells in primary culture: Detection of the ganglio and lacto series gangliosides (1991) (4)
- Isolation and separation of gangliosides on a new form of glass bead ion exchanger. (1980) (4)
- Which glycolipids are the autoantigens of cytoplasmatic islet cell antibodies? (1992) (3)
- Lipid analyses of human brain rafts (2003) (3)
- Accumulation of sulfatide in neuronal and glial cells of arylsulfatase A deficient mice (2004) (3)
- A high-sensitivity immuno-chemiluminescence technique for detection of oligoclonal IgG and IgM in unconcentrated cerebrospinal fluid. (1994) (3)
- Contents Vol. 15, 2003 (2003) (2)
- Glioma-Associated Gangliosides (1987) (2)
- Ganglioside mapping of a human medulloblastoma xenograft (2004) (2)
- The presence of antibrain antibodies in the CSF of some Alzheimer disease patients: correlation with CSF parameters (1990) (2)
- Human glioma-associated gangliosides for monoclonal antibody production (1985) (1)
- To Cohere and Act as One: IAU—The Global Voice of Higher Education (2021) (1)
- Patients with Primary Brain Tumours Have Elevated Serum Titres of Antibodies to the Myelin Glycolipid Sulphatide (2001) (1)
- Presence of sulphatide (3'-sulphogalactosylceramide) in pericytes in the choroid layer of the eye: sharing of this glycolipid autoantigen with islets of Langerhans (1996) (1)
- DISTRIBUTION OF GANGLIOSIDE GD3 IN CULTURED HUMAN TUMOR CELLS OF NEUROECTODERMAL ORIGIN AS DEFINED BY ANTI-GD3 MONOCLONAL ANTIBODIES: 12 (1989) (1)
- TOXIN ABSORPTION IN CHOLERA (1981) (0)
- DETERMINATION OF GM2 IN CULTURED HUMAN GLIOMA, MEDULLOBLASTOMA AND NEUROBLASTOMA CELLS WITH EPITOPE-DEFINED MONOCLONAL ANTIBODIES (MAbs): 165 (1989) (0)
- Preparative Centrifugation: A Practical Approach edited by D. Rickwood. Oxford University Press, New York, 1993, ISBN 0-19-963208-1, $78.00 (cloth); ISBN 0-19-963211-1, $44.00 (paper). (2002) (0)
- High-dose intravenous immunoglobulin therapy improved muscle strength in two patients with multifocal motor neuropathy (1994) (0)
- Subject Index Vol. 15, 2003 (2003) (0)
- C16:0 Sulfatide Inhibits Insulin Secretion in Rat -Cells by Reducing the Sensitivity of K ATP Channels to ATP (2006) (0)
- HUMAN GLIOMA (HGL) XENOGRAFTS AND ESTABLISHED HGL CELL LINES AS ANALYTICAL AND PREPARATIVE SOURCES OF GANGLIOSIDES (1986) (0)
- Oral administration to NOD mice of diabetic autoantigens: Pure and linked to cholera toxin B subunit (1997) (0)
- Higher education based on cooperation and interdisciplinarity has a key role in a global sustainable development (2022) (0)
- EXPRESSION OF GD2 BY TUMOR CELL LINES OF NEUROECTODERMAL ORIGIN AND HUMAN GLIOMAS AS DEFINED BY AN EPITOPE-DEFINED ANTI-GD2 MONOCLONAL ANTIBODY: 179 (1990) (0)
- Learning to be able to learn and teach - Introduction to studies in higher education. (2005) (0)
- Biochemistry of myelin glyco-conjugates (1992) (0)
- Application of a panel of antiganglioside monoclonal antibodies to cytologic specimens. (1992) (0)
- Sulfatide is expressed in neurons and astrocytes and accumulates at degradation deficiency (2003) (0)
- Use of sulfatide for treatment of diabetes (2001) (0)
- Sulfatide Is Present in the Insulin Secretory Granules in Human Beta Cells, and Facilitates Insulin Monomerization (2002) (0)
- Lipid composition of caveolae and of surrounding plasma membrane in rat adipocytes (2012) (0)
- O-27-8 Cell membrane components in the thalamus of schizophrenic brains (1996) (0)
- Acknowledgement to reviewers (2004) (0)
- New Glycolipidkomplekser and their use (1997) (0)
- Obituary—Lars Svennerholm (2000) (0)
This paper list is powered by the following services:
Other Resources About Pam Fredman
What Schools Are Affiliated With Pam Fredman?
Pam Fredman is affiliated with the following schools:
